InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,244.80
(
0.27%
)
Dow Jones
39,872.99
(
0.17%
)
Brent Oil
82.13
(
-0.39%
)
Bitcoin
69,821.35
(
-0.44%
)
Post# of 251888
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119670
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 233055

Monday, 03/29/2021 4:22:02 PM

Monday, March 29, 2021 4:22:02 PM

Post# of 251888
PCVX delays IND filing for VAX-24:

https://finance.yahoo.com/news/vaxcyte-reports-fourth-quarter-full-201000080.html

“While our team has completed several additional key steps to support the IND application submission for VAX-24, in light of the combination of ongoing work to manufacture the 24 conjugated drug substances, capacity constraints at our contract manufacturing organization and, to a lesser degree, the impact of the COVID-19 pandemic, we are changing the expected timing of our VAX-24 IND application submission to between January and June 2022.”

The prior guidance for the IND filing had been 2H21. With the IND filing now expected in 1H22, the guidance for reporting phase-1/2 top-line data is “between late 2022 and early 2023.”

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up